When a particularly deadly pathogen appears, any delay in identifying it can slow the development of treatments and diagnostic tests. But until recently, identifying a pathogen usually required some advance knowledge of its genetic makeup. Now a team led by W. Ian ­Lipkin, director of the Center for Infection and Immunity at ­Columbia University's Mailman School of Public Health, has shown how to use advanced gene-sequencing tech­nology to identify even the most mysterious pathogen. Lipkin starts by partly isolating a pathogen's genetic material from that of its human host. Then he sequences the ­sample using technology developed by 454 Life Sciences of Branford, CT; unlike other systems, 454's doesn't require prior information about the sequence you are looking for. Finally, ­Lipkin searches a database to see if any known sequences match the ones he's identified.

Select from the choices above to read the entire article.